Akèy › Artrit Rematoid › Texas › Houston
Etid klinik pou Artrit Rematoid nan Houston, TX
11 etid pou Artrit Rematoid ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
RA-PRO PRAGMATIC TRIAL
Ap rekriteFaz 3
- Baylor University, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- UT MD Anderson Cancer Center, Houston
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Ap rekriteFaz 2
- Accurate Clinical Research - Houston /ID# 272271, Houston
- Private Practice - Dr. Laila A. Hassan /ID# 272297, Houston
- Care & Cure Clinic /ID# 281684, Houston
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Ap rekriteFaz 2
- Accurate Clinical Management, Houston
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Ap rekriteFaz 2
- Accurate Clinical Management LLC, Houston
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Ap rekriteFaz 1/2
- Nkarta Investigational Site, Houston
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Ap rekriteFaz 2
- Artiva Investigational Site Bellaire, Bellaire · 7 mi lwen
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Ap rekriteFaz 2
- Research Site, Houston
- Research Site, Houston
R-2487 in Patients With Rheumatoid Arthritis
Ap rekriteFaz 1
- Prolato Clinical Research Center, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Ap rekriteEtid obsèvasyon
- M D Anderson Cancer Center, Houston
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
Ap rekriteEtid obsèvasyon
- The University of Texas MD Anderson Cancer Center, Houston
Etid Artrit Rematoid nan lòt vil
- New York City, NY10 etid
- Durham, NC8 etid
- Altoona, PA7 etid
- Aurora, CO7 etid
- Dallas, TX7 etid
- Boston, MA7 etid
- San Diego, CA6 etid
- Plantation, FL6 etid
- Chicago, IL6 etid
- Miami, FL5 etid
- West Palm Beach, FL5 etid
- Mesquite, TX5 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.